Showing all 2 results
Mirabegron Extended-Release Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hydrophilic Matrix ER Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute physical stability of the extended-release polymers.
Active Ingredient Strength Primary Clinical Function Mirabegron Ph.Eur./USP 25 mg (ER) Initiation / Renal Standard: Base therapeutic unit for assessing patient tolerance and for use in patients with severe renal or hepatic impairment. Mirabegron Ph.Eur./USP 50 mg (ER) Global Urology Standard: High-efficacy adult maintenance therapy for maximum suppression of urge urinary incontinence and detrusor overactivity. Excipients Polyethylene Oxide / Hypromellose (HPMC) / Butylated Hydroxytoluene (BHT) / Magnesium Stearate / Premium Opadry Film Swellable ER Polymer / Hydrophilic Matrix Base / Antioxidant / Lubricant (Engineered specifically to form an impenetrable, slow-eroding gel matrix in the GI tract, strictly metering the release of the active ingredient over 24 hours) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 30 (Optimized specifically for strict 30-day chronic urology dispensing regimens).
Solifenacin Succinate Tablets
FreeA Solifenacin Succinate tablet is an antimuscarinic (anticholinergic) medication used to treat symptoms of an overactive bladder, such as frequent or urgent urination and urinary incontinence.
